Original Research
Published on 21 Jan 2026
Real-world use of efgartigimod in acetylcholine receptor antibody–positive generalized myasthenia gravis: experience from two centers in Greece and Cyprus
- 1,118 views
Original Research
Published on 21 Jan 2026
Original Research
Published on 21 Jan 2026
Original Research
Accepted on 20 Jan 2026
Review
Accepted on 20 Jan 2026
Systematic Review
Published on 20 Jan 2026
Systematic Review
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Correction
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Systematic Review
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Review
Published on 20 Jan 2026
Review
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Original Research
Accepted on 19 Jan 2026
Original Research
Published on 21 Jan 2026
Original Research
Published on 20 Jan 2026
Original Research
Published on 20 Jan 2026
Review
Published on 20 Jan 2026
Systematic Review
Published on 19 Jan 2026
Original Research
Published on 19 Jan 2026
Systematic Review
Published on 19 Jan 2026